Results for tag: "Histrelin"

Histrelin is a type of drug used to treat prostate cancer. It is a synthetic form of gonadotropin-releasing hormone (GnRH) agonist, which works by blocking the production of testosterone, a hormone that can fuel the growth of prostate cancer cells. Histrelin is typically administered as an implant, which is placed under the skin and slowly releases the drug over a period of time. It is used to treat advanced prostate cancer, and is often used in combination with other treatments such as radiation therapy and chemotherapy. Histrelin is a relatively new drug, and is still in the process of being approved for use in many countries. It is currently approved in the United States, Canada, and several European countries. The Histrelin market is a growing one, as the drug is increasingly being used to treat prostate cancer. It is expected to continue to grow in the coming years, as more countries approve its use and more patients are treated with it. Companies in the Histrelin market include Endo Pharmaceuticals, Ferring Pharmaceuticals, and Takeda Pharmaceuticals. Show Less Read more